Eksigent Announces Major Expansion for HPLC Manufacturing and Service

23-Jul-2009 - Ireland

Eksigent Technologies announced that it will increase manufacturing capacity by 40 percent to meet strong demand for its HPLC products.

"The need for this increase in product build capability is being driven by higher than expected customer demand for both our cHiPLC®-nanoflex for proteomics, introduced in February of this year, and our ExpressHT-Ultra HPLC System for ADME-Tox and DMPK studies, introduced last fall," stated David Neyer, vice president and co-founder of Eksigent. "We are also actively recruiting for field service personnel to ensure that customer installations are maintained at our traditionally short lead times."

Eksigent's Board of Directors approved spending last month for additional equipment, tools and staff. "Fortunately, the plant space was available to immediately accommodate this expansion, which will be complete next month," said Wade Guindy, Eksigent vice president of R&D, engineering and operations.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics